High ALDH activity defines ovarian cancer stem-like cells with enhanced invasiveness and EMT progress which are responsible for tumor invasion

Biochemical and Biophysical Research Communications

Volumn 495, Issue 1, 2018, Pages 1081-1088

  Li, Yiying ^a,c   Chen, Tong ^b   Zhu, Jie ^a   Zhang, Haiyan ^a   Jiang, Hua ^a   Sun, Hong ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c NANCHANG UNIVERSITY   (China)

Author keywords

ALDH activity; EMT; Invasion; Ovarian cancer stem like cells

Indexed keywords

ALDEHYDE DEHYDROGENASE; TUMOR MARKER;

AGGRESSION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL INVASION; COLONY FORMATION; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; METASTASIS; NONHUMAN; OVARIAN CANCER CELL LINE; OVARY CARCINOMA; PRIORITY JOURNAL; TUMOR INVASION; CANCER STEM CELL; ENZYME ACTIVATION; ENZYMOLOGY; METABOLISM; NEOPLASM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

ALDEHYDE DEHYDROGENASE; BIOMARKERS, TUMOR; CELL LINE, TUMOR; ENZYME ACTIVATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS;

EID: 85035101561     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2017.11.117     Document Type: Article

References (23)

1. Lengyel, E., Ovarian cancer development and metastasis. Am. J. Pathol. 177 (2010), 1053–1064.
2. Visvader, J.E., Lindeman, G.J., Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8 (2008), 755–768.
3. Malanchi, I., Santamaria-Martinez, A., Susanto, E., Peng, H., Lehr, H.A., Delaloye, J.F., Huelsken, J., Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481 (2011), 85–89.
4. Curley, M.D., Therrien, V.A., Cummings, C.L., Sergent, P.A., Koulouris, C.R., Friel, A.M., Roberts, D.J., Seiden, M.V., Scadden, D.T., Rueda, B.R., Foster, R., CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells 27 (2009), 2875–2883.
5. Zhang, S., Balch, C., Chan, M.W., Lai, H.C., Matei, D., Schilder, J.M., Yan, P.S., Huang, T.H., Nephew, K.P., Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 68 (2008), 4311–4320.
6. Gao, M.Q., Choi, Y.P., Kang, S., Youn, J.H., Cho, N.H., CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene 29 (2010), 2672–2680.
7. Szotek, P.P., Pieretti-Vanmarcke, R., Masiakos, P.T., Dinulescu, D.M., Connolly, D., Foster, R., Dombkowski, D., Preffer, F., Maclaughlin, D.T., Donahoe, P.K., Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 11154–11159.
8. Silva, I.A., Bai, S., McLean, K., Yang, K., Griffith, K., Thomas, D., Ginestier, C., Johnston, C., Kueck, A., Reynolds, R.K., Wicha, M.S., Buckanovich, R.J., Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res. 71 (2011), 3991–4001.
9. Yoshida, J., Horiuchi, A., Kikuchi, N., Hayashi, A., Osada, R., Ohira, S., Shiozawa, T., Konishi, I., Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression. Med. Mol. Morphol. 42 (2009), 82–91.
10. Long, H., Xie, R., Xiang, T., Zhao, Z., Lin, S., Liang, Z., Chen, Z., Zhu, B., Autocrine CCL5 signaling promotes invasion and migration of CD133+ ovarian cancer stem-like cells via NF-kappaB-mediated MMP-9 upregulation. Stem Cells 30 (2012), 2309–2319.
11. Singh, A., Settleman, J., EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29 (2010), 4741–4751.
12. Chen, D., Zhang, Y., Wang, J., Chen, J., Yang, C., Cai, K., Wang, X., Shi, F., Dou, J., MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition. J. Ovarian Res., 6, 2013, 50.
13. Ginestier, C., Hur, M.H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C.G., Liu, S., Schott, A., Hayes, D., Birnbaum, D., Wicha, M.S., Dontu, G., ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1 (2007), 555–567.
14. Clay, M.R., Tabor, M., Owen, J.H., Carey, T.E., Bradford, C.R., Wolf, G.T., Wicha, M.S., Prince, M.E., Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head neck 32 (2010), 1195–1201.
15. Su, Y., Qiu, Q., Zhang, X., Jiang, Z., Leng, Q., Liu, Z., Stass, S.A., Jiang, F., Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer Epidemiol. Biomarkers Prev. 19 (2010), 327–337.
16. Sharrow, A.C., Perkins, B., Collector, M.I., Yu, W., Simons, B.W., Jones, R.J., Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: towards targeted stem cell therapy. Gynecol. Oncol. 142 (2016), 341–348.
17. C. National Research Council Committee for the Update of the Guide for the, A. Use of Laboratory, the National Academies Collection: Reports Funded by National Institutes of Health, Guide for the Care and Use of Laboratory Animals, 2011, National Academies Press (US) National Academy of Sciences, Washington (DC).
18. Yang, D., Sun, Y., Hu, L., Zheng, H., Ji, P., Pecot, C.V., Zhao, Y., Reynolds, S., Cheng, H., Rupaimoole, R., Cogdell, D., Nykter, M., Broaddus, R., Rodriguez-Aguayo, C., Lopez-Berestein, G., Liu, J., Shmulevich, I., Sood, A.K., Chen, K., Zhang, W., Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell 23 (2013), 186–199.
19. Mani, S.A., Guo, W., Liao, M.J., Eaton, E.N., Ayyanan, A., Zhou, A.Y., Brooks, M., Reinhard, F., Zhang, C.C., Shipitsin, M., Campbell, L.L., Polyak, K., Brisken, C., Yang, J., Weinberg, R.A., The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 (2008), 704–715.
20. Jiang, H., Lin, X., Liu, Y., Gong, W., Ma, X., Yu, Y., Xie, Y., Sun, X., Feng, Y., Janzen, V., Chen, T., Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment. Mol. Med. 18 (2012), 1197–1208.
21. Hennessy, B.T., Gonzalez-Angulo, A.M., Stemke-Hale, K., Gilcrease, M.Z., Krishnamurthy, S., Lee, J.S., Fridlyand, J., Sahin, A., Agarwal, R., Joy, C., Liu, W., Stivers, D., Baggerly, K., Carey, M., Lluch, A., Monteagudo, C., He, X., Weigman, V., Fan, C., Palazzo, J., Hortobagyi, G.N., Nolden, L.K., Wang, N.J., Valero, V., Gray, J.W., Perou, C.M., Mills, G.B., Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res. 69 (2009), 4116–4124.
22. Sarrio, D., Franklin, C.K., Mackay, A., Reis-Filho, J.S., Isacke, C.M., Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties. Stem Cells 30 (2012), 292–303.
23. Flesken-Nikitin, A., Hwang, C.I., Cheng, C.Y., Michurina, T.V., Enikolopov, G., Nikitin, A.Y., Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche. Nature 495 (2013), 241–245.